Cargando…

Imeglimin‐mediated glycemic control in maternally inherited deafness and diabetes

Mitochondrial dysfunction causes maternally inherited deafness and diabetes (MIDD). Herein, we report improved glycemic control in a 47‐year‐old Japanese woman with MIDD using imeglimin without major adverse effects. Biochemical tests and metabolome analysis were performed before and after imeglimin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishibashi, Ryoichi, Hirayama, Kiichi, Watanabe, Suzuka, Okano, Kosuke, Kuroda, Yuta, Baba, Yusuke, Kanayama, Takuma, Ito, Chiho, Kasahara, Keisuke, Aiba, Saki, Iga, Ryo, Ohtani, Ryohei, Inaba, Yosuke, Koshizaka, Masaya, Maezawa, Yoshiro, Yokote, Koutaro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688119/ https://www.ncbi.nlm.nih.gov/pubmed/37715448 http://dx.doi.org/10.1111/jdi.14085

Ejemplares similares

Lifetime extension and the recent cause of death in Werner syndrome: a retrospective study from 2011 to 2020
por: Kato, Hisaya, et al.
Publicado: (2022)

Continuous glucose monitoring reveals hypoglycemia risk in elderly patients with type 2 diabetes mellitus
por: Ishikawa, Takahiro, et al.
Publicado: (2017)

Human glomerular transcriptome of diabetic kidneys: Can the podocyte cytoskeleton be a therapeutic target?
por: Maezawa, Yoshiro, et al.
Publicado: (2018)

N-3 polyunsaturated fatty acids improve lipoprotein particle size and concentration in Japanese patients with type 2 diabetes and hypertriglyceridemia: a pilot study
por: Ide, Kana, et al.
Publicado: (2018)

Optical coherence tomography findings in three patients with Werner syndrome
por: Nagai, Tatsuya, et al.
Publicado: (2022)

Effects of Sodium Glucose Co-Transporter 2 Inhibitors in Type 1 Diabetes Mellitus on Body Composition and Glucose Variabilities: Single-Arm, Exploratory Trial
por: Baba, Yusuke, et al.
Publicado: (2021)

Sodium-Glucose Cotransporter 2 Inhibitors Improve Chronic Diabetic Macular Edema
por: Takatsuna, Yoko, et al.
Publicado: (2020)

Cell biology of diabetic nephropathy: Roles of endothelial cells, tubulointerstitial cells and podocytes
por: Maezawa, Yoshiro, et al.
Publicado: (2015)

Updates on dyslipidemia in patients with diabetes
por: Ide, Shintaro, et al.
Publicado: (2023)

Werner syndrome: a model for sarcopenia due to accelerated aging
por: Yamaga, Masaya, et al.
Publicado: (2017)

Serum podocalyxin levels correlate with carotid intima media thickness, implicating its role as a novel biomarker for atherosclerosis
por: Shoji, Mayumi, et al.
Publicado: (2018)

Sodium-Glucose Co-Transporter 2 Inhibitors Reduce Macular Edema in Patients with Diabetes mellitus
por: Tatsumi, Tomoaki, et al.
Publicado: (2022)

Comparison of Visceral Fat Reduction by Ipragliflozin and Metformin in Elderly Type 2 Diabetes Patients: Sub-Analysis of a Randomized-Controlled Study
por: Koshizaka, Masaya, et al.
Publicado: (2020)

Multidrug use positively correlates with high-risk prescriptions in the Japanese elderly: a longitudinal study
por: Arai, Sayaka, et al.
Publicado: (2019)

Stimulatory effect of imeglimin on incretin secretion
por: Yingyue, Quan, et al.
Publicado: (2023)

Helicobacter cinaedi infection in patients with diabetes: a case report
por: Ishibashi, Ryoichi, et al.
Publicado: (2015)

Correction of Hypercortisolemia with an Improved Cognitive Function and Muscle Mass after Transsphenoidal Surgery in an Older Patient with Cushing's Disease
por: Terayama, Ryo, et al.
Publicado: (2022)

Weight loss improves inflammation by T helper 17 cells in an obese patient with psoriasis at high risk for cardiovascular events
por: Maezawa, Yoshiro, et al.
Publicado: (2023)

Antihypertensive Effects of Esaxerenone in Older Patients with Primary Aldosteronism
por: Fujimoto, Masanori, et al.
Publicado: (2023)

Pharmacokinetics of Imeglimin in Caucasian and Japanese Healthy Subjects
por: Fouqueray, Pascale, et al.
Publicado: (2022)

Fibroblasts from different body parts exhibit distinct phenotypes in adult progeria Werner syndrome
por: Kato, Hisaya, et al.
Publicado: (2021)

Assessing Patient Satisfaction Following Sodium Glucose Co-Transporter 2 Inhibitor Treatment for Type 1 Diabetes Mellitus: A Prospective Study in Japan
por: Ishibashi, Ryoichi, et al.
Publicado: (2020)

A novel podocyte gene, semaphorin 3G, protects glomerular podocyte from lipopolysaccharide-induced inflammation
por: Ishibashi, Ryoichi, et al.
Publicado: (2016)

Pituitary Adenylate Cyclase-Activating Polypeptide Protects Glomerular Podocytes from Inflammatory Injuries
por: Sakamoto, Kenichi, et al.
Publicado: (2015)

Molecular Mechanisms by Which Imeglimin Improves Glucose Homeostasis
por: Yaribeygi, Habib, et al.
Publicado: (2020)

Reduced lactic acidosis risk with Imeglimin: Comparison with Metformin
por: Theurey, Pierre, et al.
Publicado: (2022)

Effects of the anti-diabetic imeglimin in hyperglycemic mice with septic shock
por: Wagner, F, et al.
Publicado: (2012)

The mechanism by which imeglimin inhibits gluconeogenesis in rat liver cells
por: Vial, Guillaume, et al.
Publicado: (2021)

An Angiotensin II Type 1 Receptor Blocker Prevents Renal Injury via Inhibition of the Notch Pathway in Ins2 Akita Diabetic Mice
por: Koshizaka, Masaya, et al.
Publicado: (2012)

Central administration of sodium-glucose cotransporter-2 inhibitors increases food intake involving adenosine monophosphate-activated protein kinase phosphorylation in the lateral hypothalamus in healthy rats
por: Takeda, Kenji, et al.
Publicado: (2021)

Imeglimin exerts favorable effects on pancreatic β-cells by improving morphology in mitochondria and increasing the number of insulin granules
por: Sanada, Junpei, et al.
Publicado: (2022)

Effects of imeglimin on mitochondrial function, AMPK activity, and gene expression in hepatocytes
por: Hozumi, Kaori, et al.
Publicado: (2023)

Calcification in Werner syndrome associated with lymphatic vessels aging
por: Ogata, Hideyuki, et al.
Publicado: (2021)

LCAT-trial-24 weeks: Protocol for a clinical study to evaluate the safety of regenerative medicine and gene therapy by the autologous transplantation of human lecithin:cholesterol acyltransferase gene-transduced human pre-adipocytes
por: Kuroda, Masayuki, et al.
Publicado: (2022)

Imeglimin: A Potential New Multi-Target Drug for Type 2 Diabetes
por: Vuylsteke, Valerie, et al.
Publicado: (2015)

Mechanism of action of Imeglimin: A novel therapeutic agent for type 2 diabetes
por: Hallakou‐Bozec, Sophie, et al.
Publicado: (2020)

Glucose-Lowering Effects of Imeglimin and Its Possible Beneficial Effects on Diabetic Complications
por: Yanai, Hidekatsu, et al.
Publicado: (2023)

Development of Imeglimin Electrospun Nanofibers as a Potential Buccal Antidiabetic Therapeutic Approach
por: Alamer, Ali A., et al.
Publicado: (2023)

Letter to the Editor: Can Imeglimin Improve the Systolic Time Intervals in Diabetes Mellitus?
por: Nishikawa, Tomoaki, et al.
Publicado: (2023)

Safety and Efficacy of Ranibizumab and Luseogliflozin Combination Therapy in Patients with Diabetic Macular Edema: Protocol for a Multicenter, Open-Label Randomized Controlled Trial
por: Ishibashi, Ryoichi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5o45gn34pjfcc031p22jce8qbe